Jazz Pharmaceuticals plc (JAZZ)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 8, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Jazz Pharmaceuticals plc's Form 10-K for the fiscal year ended December 31, 2024. They remind the company that it is ultimately responsible for… | Read Filing EDGAR |
| Jul. 29, 2025 | CORRESP | Concern from SEC | Moderate | Jazz Pharmaceuticals plc has responded to comments from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC requested clarification on the discl… | Read Filing EDGAR |
| Jul. 17, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed Jazz Pharmaceuticals plc's Form 10-K for the fiscal year ended December 31, 2024, and has issued comments requiring clarification on specific disclosures. The… | Read Filing EDGAR |